BMJ News
Latest articles and news about BMJ on AXL Media.
Latest Articles
- Large-Scale Medicaid Study Finds Prenatal Buprenorphine Exposure Does Not Increase Long-Term Neurodevelopmental Risks
Published: Apr 18, 2026
Section: Medical News
A comprehensive analysis of 2.5 million US births published in The BMJ concludes that children exposed to buprenorphine in utero face no higher risk of autism, ADHD, or speech diso...
- Comprehensive BMJ Meta-Analysis Questions Clinical Efficacy of Kinesio Taping for Chronic Musculoskeletal Pain and Mobility
Published: Apr 2, 2026
Section: Health
A massive data synthesis published in BMJ Evidence-Based Medicine suggests that Kinesio taping provides only uncertain, short-term relief for muscle and joint conditions. Researche...
- Comprehensive Clinical Review Casts Significant Doubt on the Long-Term Efficacy of Kinesio Taping for Musculoskeletal Pain and Mobility
Published: Apr 1, 2026
Section: Medical News
A pooled data analysis of 128 systematic reviews has found that the clinical benefits of Kinesio Taping (KT-tape) are "very uncertain," offering at best only marginal, short-term r...
- World-First Australian Clinical Trial Reduces Post-Stroke Falls by 33% Through Tailored Home-Based Intervention Program
Published: Mar 24, 2026
Section: Medical News
Researchers from Macquarie University and the University of Sydney have developed the "Falls After Stroke Trial" (FAST), a non-drug intervention that significantly cuts injury risk...
- Long-Term US Study Confirms Neurodevelopmental Risks of Valproate in Pregnancy While Validating Safety of Alternative Epilepsy Medications
Published: Mar 13, 2026
Section: Medical News
A comprehensive analysis of two decades of US insurance data has reinforced the link between prenatal valproate exposure and disorders such as ADHD and autism. The study, published...
- Medical Experts Call for Overhaul of Cosmetic Surgery Laws to Combat Surge in Complications and High-Risk Foreign Tourism
Published: Mar 13, 2026
Section: Health
As the global cosmetic market prepares to exceed $180 billion, researchers are urging the UK government to implement strict regulatory reforms to protect patients from increasingly...
- Wegovy Linked To Higher Risks Of Ischaemic Optic Neuropathy And Sudden Vision Loss Than Other Semaglutide Medications
Published: Mar 11, 2026
Section: Health
A comprehensive analysis published in the British Journal of Ophthalmology suggests that Wegovy, a high-dose semaglutide used for weight loss, carries a significantly higher risk o...